Re: Adrean et al.: Consistent long-term therapy of neovascular age-related macular degeneration managed by 50 or more anti-VEGF injections using a treat-extend-stop protocol (Ophthalmology. 2018;125:1047-1053).

Jung, Jesse J; Kaden, Talia R; Freund, K Bailey

Re: Adrean et al.: Consistent long-term therapy of neovascular age-related macular degeneration managed by 50 or more anti-VEGF injections using a treat-extend-stop protocol (Ophthalmology. 2018;125:1047-1053).

Jung, Jesse J; Kaden, Talia R; Freund, K Bailey.

Afiliação

Jung JJ; East Bay Retina Consultants, Inc., Oakland, California; Department of Ophthalmology, University of California, San Francisco, San Francisco, California.
Kaden TR; Vitreous Retina Macula Consultants of New York, New York, New York; LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear and Throat Institute, New York, New York; Department of Ophthalmology, New York University Medical Center, New York, New York.
Freund KB; Vitreous Retina Macula Consultants of New York, New York, New York; LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear and Throat Institute, New York, New York. Electronic address: kbfnyf@aol.com.

Ophthalmology ; 125(12): e83-e84, 2018 12.

Article em En | MEDLINE | ID: mdl-30343939

Assuntos

Degeneração Macular; Fator A de Crescimento do Endotélio Vascular; Bevacizumab; Humanos; Ranibizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fator A de Crescimento do Endotélio Vascular / Degeneração Macular Tipo de estudo: Guideline Limite: Humans Idioma: En Revista: Ophthalmology Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google